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A B S T R A C T
Introduction. Type 2 diabetes negatively impacts sexual health. Only limited information is available regarding
sexual health among sexually inactive patients with type 2 diabetes.
Aim. The aim of this study was to examine the prevalence of sexual concerns among sexually active and sexually
inactive men and women with type 2 diabetes and of sexual dysfunction (SD) among sexually active.
Methods. Data from the Anglo–Danish–Dutch Study of Intensive Treatment in People with Screen-Detected
Diabetes in Primary Care-Denmark study was used. A total of 1,170 Danish patients with screen-detected type 2
diabetes attended a health examination, including assessment of sexual concerns using self-report questionnaires and
of SD using the Female Sexual Function Index (FSFI-R) and the International Index of Erectile Function (IIEF-5)
instruments.
MainOutcomeMeasures. The main outcome measures used regarding sexual concerns are the following: prevalence
of failure to ﬁll sexual needs, of experiencing sexual distress, ﬁnding it important to have a good sexual life, and
additionally, prevalence of SD.
Results. Data regarding sexual activity status during the last 12 months were available among 583 men and 377
women. Seventeen percent of men and 47% of women reported to be sexually inactive, among whom 57% of men
and 42% of women reported failure to ﬁll sexual needs; 31% of men and 10% of women that it was important to have
a good sexual life, and 32% of men and 11% of women that they were experiencing sexual distress. Around half of
men and women were excluded from the SD analysis, mainly because of reporting lack of sexual intercourse during
the last 4 weeks. Among those included, 54% of men and 12% of women were found to have SD.
Conclusions. Sexual inactivity is highly prevalent among middle-aged and older men and women with early type 2
diabetes and these patients often have sexual concerns. The high exclusion rates when assessing SD using the FSFI-R
and IIEF-5 instruments makes it difﬁcult to draw conclusions regarding the prevalence. Sexual health should be
broadly assessed in both sexually active and sexually inactive people with type 2 diabetes. Bjerggaard M, Charles
M, Kristensen E, Lauritzen T, Sandbæk A, and Giraldi A. Prevalence of sexual concerns and sexual
dysfunction among sexually active and inactive men and women with screen-detected type 2 diabetes. Sex
Med 2015;3:302–310.
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Introduction
Sexual well-being is positively associated withquality of life [1]. Type 2 diabetes negatively
interferes with sexual health and function [2].
Previous research addressing sexuality among
men and women with type 2 diabetes mainly
describe sexual dysfunction (SD) assessed using
screening instruments [3,4]. However, most
widely used instruments for sexual function
assessment primarily describe men and women
who are sexually active, often with a partner [3,5].
People with type 2 diabetes are often middle-aged
or older, and advancing age is usually related to
reduced intimate contact or sexual activities and
more physical sexual problems [6]. In previous
studies of SD among people with type 2 diabetes,
up to 50% of subjects have been excluded due to
lack of sexual activity [7]. Thus, little is known
about sexuality among sexually inactive people
with type 2 diabetes. Previous research has shown
that sexuality is also a positive factor in life among
people who are not sexual active [8]. Therefore,
more knowledge on sexuality among sexually
inactive is desirable.
Sexuality comprises many levels of sexual
behavior than having sexual intercourse. Thus,
people’s sexual well-being may not necessarily
dependent on whether they have a SD or have
sexual intercourse or not [9]. Whether a person
has sexual concerns might therefore be a better
indicator of their actual sexual well-being.
To our knowledge, no previous studies have
examined sexual concerns, among both sexually
active and inactive men and women with type 2
diabetes. Such knowledge may be desirable for
identifying sexual problems important to the
patient [9,10].
The Danish arm of the ADDITION study
(Anglo–Danish–Dutch Study of Intensive Treat-
ment In People with Screen-Detected Diabetes in
Primary Care) [11] contains information of both
sexual concerns (using self-reported question-
naires) and of SD (using previously reported
instruments) and do therefore provides a unique
opportunity to broadly assess sexual health in a
well-characterized cohort of men and women with
screen-detected type 2 diabetes.
In the present study, our main hypothesis was
that a high percentage of both sexually active and
inactive men and women with type 2 diabetes do
not get their sexual needs fulﬁlled, and that this is
distressing for them. We hypothesized that men
more often than women report that a good sexual
life is important as well as they more often have a
SD.
Aims
The aims of this study were to describe self-
reported sexual concerns. This will be done by
reporting the prevalence of: (i) failure to ﬁll sexual
needs; (ii) experiencing sexual distress; and (iii)
ﬁnding it important to have a good sexual life
among both sexually active and inactive; and by
describing the prevalence of SD among sexually
active men and women with type 2 diabetes.
Methods
Sample
Data for this study were collected at the follow-up
examination of the ADDITION Denmark study.
The design and rationale of the ADDITION
study have been reported previously [11]. Brieﬂy,
ADDITION Denmark comprises two phases:
a screening phase and a pragmatic cluster-
randomized parallel group trial. All 40- to 69-year-
old patients in 190 general practices in Denmark
were invited to participate in a stepwise screening
program for type 2 diabetes. Individuals were diag-
nosed according to the World Health Organiza-
tion criteria as previously described [12]. Those
diagnosed with type 2 diabetes were randomized
to either routine care of diabetes or intensive treat-
ment. Overall, 1,533 eligible patients with screen-
detected diabetes agreed to participate in the trial.
The study was approved by the local ethics com-
mittee and conducted in accordance with the prin-
ciples of the 1996 Helsinki Declaration. All
participants provided informed consent.
After an average of 5 years of follow-up, 1,170
(76%) of these participants were reexamined in
test centers and asked to complete self-report mea-
sures, including measures of sexuality. A total of
414 women and 604 men (86% and 88% of the
study population, respectively) answered one or
more questions on sexuality and were included in
the present study. Supplementary Figure S1 dis-
plays the participant ﬂow.
Subject Measures and Study Procedures
Health assessments at follow-up were performed
by centrally trained staff unaware of study group
allocation, and following standard operating pro-
cedures. Examinations included biochemical,
anthropometric, and questionnaire measures [13].
Sexual measures were assessed using self-report
questionnaires. Participants completed questions
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in private and then submitted them to study per-
sonnel. The use of medication to treat erectile
dysfunction (ED) (phosphodiesterase type 5
inhibitors [PDE5 inhibitors]) was evaluated based
on data regarding prescriptions redeemed from
the pharmacy.
Outcome Measures
Study participants were asked eight general sex-
related questions that have been previously used in
big national health surveys (Supplementary
Figure S2)—of which, questions 3, 5, and 8.4 were
selected for this present study [14]. Based on the
answers to these questions, three outcomes were
deﬁned:
1. “My sexual life does not meet my sexual needs,”
if answering “no” or “not at all” to the question
“Does your sexual life meet your sexual needs?”
2. “It is important for me to have a good sexual
life,” if answering “very important” or “impor-
tant” to the question “How important is it for you
to have a good sexual life?”
3. “My sexual life gives me a lot of distress,” if
answering, “agree a lot” or “agree” to the state-
ment “My sexual life gives me a lot of distress.”
To examine sexual functioning, women and men
were asked to complete the abbreviated versions of
the Female Sexual Function Index (FSFI-R) and
the International Index of Erectile Function
(IIEF-5), respectively. The FSFI-R is a ﬁve-item
version of the 19-item FSFI [4,15,16], which has
adequate psychometric properties that are essen-
tially equivalent to those of the full-scale measure
[5]. The items are scored on a 5-point Likert-type
scale, with responses ranging from 5 (least func-
tional) to 1 (most functional), or 0 if the respondent
has had no sexual intercourse, no sexual activity, or
no partner. Respondents giving an answer of 0 are
excluded when using the FSFI-R instrument. The
FSFI-R total score is the sum of all the items
representing each domain of sexual functioning,
added to the mean score of the two items assessing
satisfaction, and can range from 6 to 30. A score of
22.75 or more indicates overall SD. FSFI-R scores
can be used to estimate the prevalence of a speciﬁc
sexual problem by domain-speciﬁc item analysis,
combining the percentage of women that score in
the two lowest categories in each item (almost
never, never, or a few times)—except for the pain
domain where the opposite is true.
The IIEF-5—an abridged ﬁve-item version of
the 15-item IIEF—is a validated self-administered
questionnaire for clinical assessment of ED [3].
Each IIEF-5 item is scored on a ﬁve-point ordinal
scale ranging from 1 (least functional) to 5 (most
functional), with a response of 0 given if the patient
had no sexual activity. Respondents who give an
answer of 0 are excluded when using the IIEF-5
instrument. Hence, the possible scores for the
IIEF-range from 5 to 25, with a score of 21 or less
indicating overall SD. Using this instrument, ED
can be classiﬁed into four categories: severe (5–7),
moderate (8–11), mild to moderate (12–16), mild
(17–21), and no ED (22–25).
Data Analysis and Statistics
Sample characteristics at follow-up were presented
as unadjusted means, medians, or percentages.
Sample characteristics were presented stratiﬁed
according to sexual activity status.Men and women
were considered sexually active if they answered,
“yes” to the question “In the last 12 months, have you
been sexually active (any activity that is sexually arous-
ing to you, including masturbation)?” Comparisons
between sexually active and sexually inactive par-
ticipants and between people with and without SD
were made using Pearson chi-squared test for cat-
egorical variables, t-tests for continuous data, and
Mann–Whitney U-test for non-normally distrib-
uted data. The prevalences of the sexual character-
istics were described separately for sexually active
and inactive participants. To assess the validity of
the determined prevalences, responders were com-
pared with non-responders (people who did not
answer relevant sexual questions). The overall
prevalence of SD was calculated as the number of
participants with SDdivided by the total number of
participants included in the SD analysis. We found
no interaction between treatment groups and
sexual outcomes; therefore, all analyses were
pooled. All analyses were conducted using Stata
software (version 12, StataCorp LP, College
Station, TX, USA) and P < 0.05 was considered to
indicate statistical signiﬁcance.
Results
Among the 1,018 study participants, data regarding
sexual activity during the last 12months were avail-
able from 377 women and 583 men of whom 176
women and 102 men reported to be sexually inac-
tive. Table 1 presents the patients’ follow-up char-
acteristics and show that sexual inactive differ
signiﬁcantly from sexual active on the following
characteristics: The proportion of macro-vascular
illness was found to be nearly twofold higher in
sexually inactive womenwith diabetes than in sexu-
ally active women with diabetes (P = 0.042); the
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mean duration of diabetes in years was longer in
sexually inactive men than in sexually active men
(P = 0.022) and sexually inactive people were older
than sexually active people in both sexes
(P < 0.001).
Sexual Characteristics
Five hundred nine men and 348 women answered
questions regarding sexual concerns. Table 2 pres-
ents the results. Among those who reported no
sexual activity during the last 12 months, 165
women and 96men provided reasons for this lack of
sexual activity, including no interest (35% of
women and 36% of men), a physical problem that
made it difﬁcult or unpleasant (4% of women and
32% of men), no partner (34% of women and 13%
of men), that their partner had a physical problem
that made it difﬁcult or unpleasant (16% of women
and 14% of men), or something else (19% of
women and 20% of men). Among the men who
answered “something else,” one-third reported
that this reason was ED.
Compared with responding women, non-
responding women were older (67.4 vs. 65.0
years). Compared with responding men, non-
responding men were older (68.1 vs. 64.9 years)
and less likely to be taking beta-blockers (8.1 vs.
26.9%). No other statistically signiﬁcant differ-
ences were found (data not shown).
SD
The analysis of SD included 163 sexually active
women (mean age, 62.8 years) and 345 sexually
active men (mean age, 63.5 years). A total of 251
women (60%) were excluded due to a lack of sexual
activity or sexual intercourse (n = 186) or no
partner (n = 28) during the last 4 weeks, or because
they did not provide complete data (n = 37). A total
of 259 men (43%) were excluded due to a lack of
sexual intercourse during the last 4 weeks (n = 223),
or because they did not provide complete data
(n = 36).
We determined the prevalences of SD among
sexually active women (Table 3) and men (Table 4).
Twenty-one percent ofmenwithEDhad redeemed
prescriptions for ED medication. Among partici-
pants with SD, 35% of women and 28% of men
reported that they experienced sexual distress.
Compared with women without SD, women with
SD were more likely to report low mental health
(42.1% vs. 16.7%). Compared with men without
SD, men with SD had signiﬁcantly higher hba1c
levels (6.4% vs. 6.3%), were more likely to report
Table 2 Prevalence of sexual characteristics stratified by sexual activity status
Women Men
Overall
N = 348
Sexually
inactive
N = 169
Sexually
active
N = 179
Overall
N = 509
Sexually
inactive
N = 98
Sexually
active
N = 411
My sexual life does not meet my sexual needs, n (%) 91 (27) 69 (42) 22 (12) 152 (30) 55 (57) 97 (24)
It is important for me to have a good sexual life, n (%) 123 (35) 17 (10) 106 (59) 338 (67) 30 (31) 308 (75)
My sexual life gives me a lot of distress, n (%) 24 (9) 13 (11) 11 (7) 90 (19) 26 (32) 64 (16)
Sexual characteristics at follow-up of participants in the Danish arm of the Anglo–Danish–Dutch Study of Intensive Treatment In People with Screen-Detected
Diabetes in Primary Care (ADDITION), who responded to sexual questions regarding needs, importance, and distress.Participants were categorized as “I do not
get my sexual needs covered” if they answered “no” or “not at all” to the question “Does your sexual life meet your sexual needs?”. Participants were categorized
as “It is important for me to have a good sexual life” if they answered “very important” or “important” to the question “How important is it for you to have a good
sexual life?”. Participants were categorized as “My sexual life gives me a lot of distress” if they answered “agree a lot” or “agree” to the statement “My sexual life
gives me a lot of distress.”
Table 3 Prevalence of overall sexual dysfunction and
domain-specific problems among sexually active women
(n = 163)
Overall 12%
Problems with sexual desire 50%
Problems with sexual arousal 34%
Problems with lubrication 36%
Problems with orgasm 36%
Lack of satisfaction with partner 8%
Lack of satisfaction with sexual life 8%
Pain during penetration 10%
A score of ≥22.75 on the Female Sexual Function Index (FSFI-R) was used as
the cut-off to define overall sexual dysfunction. Each domain in the FSFI-R
analysis was scored on a 5-point Likert-type scale. A domain-specific problem
was defined as the percentage of women who scored in the two lowest
categories for each item—except for the pain domain where the opposite was
true.
Table 4 Prevalence of erectile dysfunction, both overall
and stratified by severity, among sexually active men
(n = 345)
Overall 54%
Mild 26%
Mild–Moderate 13%
Moderate 9%
Severe 7%
A score of ≤21 on the International Index of Erectile Function (IIEF-5) was used
as the cut-off to define overall erectile dysfunction (ED). ED is classified into
four categories based on IIEF-5 scores: severe ED (5–7), moderate ED
(8–11), mild–moderate ED (12–16) and mild ED (17–21).
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low mental health (27% vs. 15%) and low physical
health (10% vs. 4%), had a higher body mass index
(30.8 vs. 29.7 kg/m2), and were older (64.2 vs. 62.6
years). Other variables did not signiﬁcantly differ
between groups (data not shown).
Discussion
The present study showed that there is a high
prevalence of sexual inactivity among middle-
aged and elderly patients with screen-detected
type 2 diabetes; that many sexually inactive
patients did not fulﬁll their sexual needs; and that
there is a high prevalence of SD in the male
population.
There are few prior studies of sexuality among
healthy Danish middle-aged and older men and
women. Two previous studies of 60-year-old men
and women showed sexual inactivity among 20%
of men and 25% of women, when sexual activity
was deﬁned as sexual intercourse within the last 12
months [17,18]. The present study showed a
similar prevalence of sexual inactivity among men,
even though our study included any activity that
was considered sexually arousing in the deﬁnition of
sexual activity. Therefore, the prevalence of sexual
inactivity was probably higher in this population of
both men and women with type 2 diabetes, com-
pared with the studies of healthy Danish men and
women, if deﬁning sexual activity as having sexual
intercourse.
Previous studies of older people without diabe-
tes have reported that sexuality is still a positive
factor in life among sexually inactive individuals [8].
Our present results showed that among half of
sexually inactive men and women with type 2 dia-
betes their sexual life did not meet their sexual
needs, and sexually inactive men and women
reported sexual distress more frequently compared
with sexually active. These results suggest that
sexually inactive men and women are concerned
about their lack of sexual activity and some are even
distressed. Therefore, clinicians and researchers
should pay attention to sexuality also among sexu-
ally inactive peoplewith type 2 diabetes and address
their concerns. There may be sexual issues that are
important to identify among sexually inactive
patients, which are overlooked if one only addresses
SD among sexually active patients.
Sexual activity was found to be related to age,
duration of diabetes and co-morbid macro-
vascular illnesses supporting the ﬁndings of previ-
ous research [2,6].
When using the IIEF and FSFI instruments to
evaluate SD, men and women who have not been
sexually active during the last 4 weeks are either
excluded or, among men, sometimes categorized as
having severe ED [5,19]. These instruments have
been criticized for these limitations. Consistent
with prior ﬁndings, our study showed extremely
high exclusion rates when using these instruments,
making it difﬁcult to draw any conclusions regard-
ing the prevalences [7,20]. Women in the present
study showed a much lower prevalence of SD com-
pared with those reported in previous studies of
women with type 2 diabetes, which have ranged
from 42% to 60% [21–23]. One can only speculate
why, but one can hypothesize that it may be due to
the exclusion of sexually inactive women or that
women with sexual problems did choose not to
answer questions related to sexuality. Among men
in the present study, the overall prevalence of ED
was similar to those reported in previous studies of
men with type 2 diabetes, which have ranged from
49% to 56% [24–26]. This cohort might, however,
differ from other cohorts with diabetes as partici-
pants were diagnosed with diabetes by screening.
Although the study was carried out during subse-
quent follow-up and the mean duration of diabetes
was around 6 years after the date of diabetes diag-
nosis, they may differ from other populations with
diabetes.
Compared with the participants included in the
analyses of SD, those who were excluded were
older. This likely contributed to an overall under-
estimation of the prevalence of SD among both
men and women in this present study.
The results of this study highlighted several
problems linked to the use of SD screenings instru-
ments. In this study, we included a question regard-
ing the patient’s reason for sexual inactivity. A
common reason given for lacking sexual activity
during the last 12 months was “Having a physical
problem that made it difﬁcult or unpleasant to have
sexual activity.” Furthermore, one-third of men
with a physical problem that made sexual activity
difﬁcult reported that this physical problem was
ED. These ﬁndings support the assumption that
exclusions of sexually inactive men leads to an
underestimation of the prevalence of SD and illus-
trate that SD must also be considered among sexu-
ally inactive patients.
Additionally, our results demonstrate that
restricting the assessment of SD to individuals who
have been sexually active within the last 4 weeks
will further exclude people who are less frequently
sexually active, which will be more common with
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increasing patient age. Instruments for assessing
SD should be modiﬁed to include people who are
more rarely sexually active, especially in older
populations.
Finally, screening for SD using only FSFI-R
and IIEF-5 might fail to identify people experienc-
ing distressing sexual issues, as these tools do not
include any evaluation of the patient’s own judg-
ment of their sexual well-being.
It may be useful to reconsider the current
assessment of sexuality in research settings, and to
revise the available screening instruments assess-
ing SD as well as other elements evaluating sexu-
ality, including sexual distress.
Among men found to have ED, only 21% was
found to receive pharmacological treatment.
These results do not directly reveal the level of
attention given to sexual issues among patients
with type 2 diabetes in general practice, but does
however suggest an insufﬁcient effort. This sus-
picion is supported by another Danish study in
which only 33% of men with type 2 diabetes
reported that their general practitioner had
brought up sexuality in the consultation [27].
The results suggest that general practitioners
could improve their sexual effort when dealing
with patients with type 2 diabetes. By raising the
topic in the consultation potential, sexual con-
cerns could be identiﬁed, the etiology could be
evaluated, and a suitable treatment could be ini-
tiated. Among men there is often an organic
component in the etiology why the treatment is
often directed toward an improvement of the
glycemic- and metabolic control and symptom-
atic treatment with for example a PDE5-inhibitor
[28]. However, there are many other opportuni-
ties, not mentioned here. Among women the
treatment possibilities are fewer due to lack of
documentation of an organic etiology [29].
However, exercise is well documented to reduce
inﬂammation [30]. Furthermore, lubricants and
hormonal replacement therapy are often effec-
tive. Finally, it might be relevant to discuss the
many alternative ways to express sexuality as
kisses and hugs, etc. with the patients.
Strengths andWeaknesses
Our study has several strengths. The population
was well described and has a high overall
response rate. Therefore there were only small
restrictions in generalizing data on sexually inac-
tivity to the target population. Furthermore, this
study did not restrict the evaluation of sexuality
to participants who were sexually active, who had
a sexual partner, or who had recently had sexual
intercourse. Being sexually active was deﬁned
according to sexual activity status during the last
12 months rather than the last 4 weeks, which
might give a more realistic picture of the extent
to which middle-aged and older people with type
2 diabetes are sexually inactive.
Our study also has several limitations. We used
self-administered questionnaires to collect infor-
mation regarding sexuality, which resulted in
respondent burden and missing data. Some
people with type 2 diabetes do not know that
sexual problems are common complications and
many are embarrassed of them, which may have
led some participants to withhold information.
Furthermore, questions used to describe sexual
concerns are developed by experts in sexology,
but are however not validated. This has to be
taken into account when concluding on the
results. Furthermore, we found that non-
responders were older compared with responders.
It is possible that non-responders are more likely
to be sexually inactive, and thus ﬁnd it less rel-
evant for them to answer questions on sexuality,
which could lead to underestimation of the prevalences
of sexually inactivity and SD. We did not ask the
participants about their sexual orientation and
gender of partner, and can therefore not elucidate
whether that has an inﬂuence on fulﬁllment of
sexual needs, sexual function or distress. We did
not include people without diabetes, and thus we
cannot determine whether the present ﬁndings
are restricted to people with type 2 diabetes.
From the study, it was not possible to get infor-
mation whether the participants had tried to seek
help for a sexual problem or if they were inter-
ested. We only had information on how many
men, had received a prescription for pharmaco-
logical treatment of ED. Finally, we did not take
into account that some conditions, like for
example testosterone deﬁciency in men, urinary
incontinence in women, and obesity are associ-
ated to diabetes and also inﬂuence sexuality nega-
tively [2,31]. These associations were not the
focus of this article, but might of course be
highly relevant to consider as a competing reason
to the sexual problems among men and women
with diabetes when dealing with these patients
clinically.
Conclusion
Sexual inactivity was found to be highly prevalent
among middle-aged and older men and women
308 Bjerggaard et al.
Sex Med 2015;3:302–310 © 2015 The Authors. Sexual Medicine published by Wiley Periodicals, Inc.
on behalf of International Society for Sexual Medicine.
with screen-detected type 2 diabetes. Many sexu-
ally inactive reported that their sexual needs were
not met, and sexually inactive experienced sexual
distress more often than sexually active. SD was
present in around half of the men and in around
one-tenth of the women. However, the present
results should be interpreted cautiously as exclu-
sion rates were extremely high and several of the
excluded patients reported SD. Only 21% of men
with ED received pharmacological treatment. We
suggest that researchers and clinicians should
broadly evaluate sexuality among both sexually
active and inactive people with type 2 diabetes.
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